ASSESSMENT OF EFFICACY OF ACTIVATED CHARCOAL FOR TREATMENT OF ACUTE T-2 TOXIN POISONING¹

Abstract

“Superactive“ charcoal was assessed for efficacy in decreasing the lethality of both oral and parenteral exposure to T-2 toxin, a fungal metabolite which can cause death or illness upon ingestion. In vitro binding studies, analyzed using the Langmuir adsorption isotherm, showed that activated charcoal had a maximal binding capacity of 0.48 mg toxin/mg charcoal and a dissociation constant of 0.078 mg charcoal/l. In vivo, orally administered, activated charcoal was assessed for treatment of acute oral or parenteral exposure to T-2 toxin in mice. Following oral toxin administration (5 mg/kg), untreated mice showed only 6% survival after 72 hr. Charcoal treatment (7 g/kg, po) either immediately or 1 hr after toxin exposure resulted in significant The views of the author do not purport to reflect the positiosns of the Department of the Army or the Department of Defense. improvement in survival with values of 100% and 75%, respectively, Following parenteral toxin exposure (2.8 mg/kg, sc), untreated and charcoat-treated (7 g/kg, po) mice showed 50% and 90% survival, respectively, after 72 hr. LD50 value for T-2 toxin, determined at 96 hr after intoxication, increased significantly from 2 mg/kg for untreated controls to 4.5 mg/kg for activated charcoal treatment.